Intravascular device infections: Epidemiology, diagnosis, and management

Cardiology in Review

Volumn 15, Issue 1, 2007, Pages 13-23

  Gandelman, Glenn ^a   Frishman, William H ^a,d   Wiese, Cristina ^b   Green Gastwirth, Vanessa ^c   Hong, Steven ^a   Aronow, Wilbert S ^a   Horowitz, Harold W ^a  

^a WESTCHESTER MEDICAL CENTER   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Endocarditis; Intravascular device; Left ventricular assist devices; Pacemakers; Prosthetic vascular devices

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; FLUCONAZOLE; GENTAMICIN; LINEZOLID; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC THERAPY; AORTA GRAFT; ARTIFICIAL HEART PACEMAKER; BACTERIAL INFECTION; BLOOD VESSEL GRAFT; CLINICAL FEATURE; CLINICAL TRIAL; CONTAMINATION; DEBRIDEMENT; DEFIBRILLATOR; DEVICE INFECTION; DEVICE REMOVAL; DIAGNOSTIC IMAGING; ENDOCARDITIS; GRAFT INFECTION; HEART ASSIST DEVICE; HUMAN; IMPLANTATION; INFECTION RATE; INFECTION RISK; INTESTINE GRAFT; LONG TERM CARE; MEDICAL LITERATURE; MICROBIOLOGICAL EXAMINATION; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATHOGENESIS; REVIEW; RISK FACTOR; SKIN FLORA; SUPERIOR CAVA VEIN SYNDROME; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME; VEIN OCCLUSION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BLOOD VESSEL PROSTHESIS; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; FOLLOW-UP STUDIES; HEART-ASSIST DEVICES; HUMANS; RISK FACTORS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 33845765215     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.crd.0000197966.53529.67     Document Type: Review

References (55)

1. Safdar N, Fine JP, Maki DG. Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med. 2005;142:451-466.
2. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2005;51:1-29.
3. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001;32:1249-1272.
4. Trohman RG, Kim MH, Pinski SL. Cardiac pacing: the state of the art. Lancet. 2004;364:1701-1719.
5. Bardt GH, Lee LL, Mark DB, et al. Amiodarone or an implantable cardioverter defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
6. 5a. von Eiff C, Jansen B, Kohnen W, et al. Infections associated with medical devices. Pathogenesis, management and prophylaxis. Drugs. 2005;65:179-214.
7. Arber N, Pras E, Copperman Y, et al. Pacemaker endocarditis: report of 44 cases and review of the literature. Medicine. 1994;73:299-305.
8. Frame R, Brodman RF, Furman S, et al. Surgical removal of infected transvenous pacemaker leads. Pacing Clin Electrophysiol. 1993;16:2343-2348.
9. Harcombe AA, Newell SA, Ludman PF, et al. Late complications following permanent pacemaker implantation or elective unit replacement. Heart. 1998;80:240-244.
10. Chua JD, Wilkoff BL, Lee I, et al. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med. 2000;133:604-608.
11. Conklin EF, Giannelli S, Nealon TF. Four hundred consecutive patients with permanent transvenous pacemakers. J Thorac Cardiovasc Surg. 1975;69:1-7.
12. Cabell CH, Heidenreich PA, Chu VH, et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J. 2004;147:582-586.
13. Camus C, Leport C, Raffi F, et al. Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal. Clin Infect Dis. 1993;17:46-55.
14. Klug D, Lacroix D, Savoye C, et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation. 1997;95:2098-2107.
15. Cacoub P, Leprince P, Nataf P, et al. Pacemaker infective endocarditis. Am J Cardiol. 1998;82:480-484.
16. Trappe HJ, Pfitzner P, Klein H, et al. Infections after cardioverter-defibrillator implantation: observation in 335 patients over 10 years. Br Heart J. 1995;73:20-24.
17. Lewis AB, Hayes DL, Holmes DR, et al. Update on infections involving permanent pacemakers: characterization and management. J Thorac Cardiovasc Surg. 1985;89:758-763.
18. Karchmer AW. Infection of prosthetic valves and intravascular devices. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone; 2000:903-917.
19. Karchmer AW, Longworth DL. Infections of intracardiac devices. Infect Dis Clin North Am. 2002;16:477-505.
20. Baddour LM, Bettmann MA, Bolger AF, et al. Nonvalvular cardiovascular device-related infections. Circulation. 2003;108:2015-2031.
21. Voet JG, Vandekerckhove YR, Muyldermans LL, et al. Pacemaker lead infection: report of three cases and review of the literature. Heart. 1999;81:88-91.
22. Chaudhary R, Simmons RL. Pathogenesis of vascular graft infections. J Vasc Surg. 1991;13:755-756.
23. Myers TJ, Khan T, Frazier OH. Infectious complications associated with ventricular assist systems. ASAIO J. 2000;46:S28-S36.
24. Piccione W. Left ventricular assist device implantation: short and long-term surgical complications. J Heart Lung Transplant. 2000;19:S89-S94.
25. Didisheim P, Rose EA, Long JW, et al. Infection with clinical ventricular assist devices: clinical therapy. ASAIO J. 2001;47:195-196.
26. Da Costa A, Lelievre H, Kirkorian G, et al. Role of the preaxillary flora in pacemaker infections: a prospective study. Circulation. 1998;97:1791-1795.
27. Mokaddem A, Bachraoui K, Sdiri W, et al. Pacemaker infections. Tunis Med. 2002;80:509-514.
28. Chamos AL, Peterson GE, Cabell CH, et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation. 2001;104:1029-1033.
29. Paniagua D, Aldrich HR, Lieberman EH, et al. Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemaker leads. Am J Cardiol. 1998;82:1130-1132.
30. Fisher AB, Chien S, Barakat AI, et al. Endothelial cellular response to altered shear stress. Am J Physiol Lung Cell Mol Physiol. 2001;281:L529-L533.
31. Bencic ML, Kosi D, Cikes I, et al. Endocarditis associated with atrial and ventricular cardiac pacing leads. Case report. Lijec Vjesn. 2002;124:310-313.
32. Durack DT, Lukes AS, Bright DK, et al. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med. 1994;96:200-209.
33. Victor F, De Place C, Camus C, et al. Pacemaker lead infection: echocardiographic features, management, and outcome. Heart. 1999;81:82-87.
34. Bracke FA, Meijer A, van Gelder LM. Pacemaker lead complications: when is extraction appropriate and what can we learn from published data? Heart. 2001;85:254-257.
35. del Rio A, Anguera I, Miro JM, et al. Surgical treatment of pacemaker and defibrillator lead endocarditis. The impact of electrode lead extraction on outcome. Chest. 2003;124:1451-1459.
36. Erdinler I, Okmen E, Zor U. Pacemaker related endocarditis: analysis of seven cases. Jpn Heart J. 2002;43:475-485.
37. O'Nunain S, Perez I, Roelke M, et al. The treatment of patients with infected implantable cardioverter-defibrillator systems. J Thorac Cardiovasc Surg. 1997;113:121-129.
38. Califf RM, Fowler V Jr, Cabell CH, et al. Novel approaches to clinical trials: device-related infections. Am Heart J. 2004;147:599-604.
39. Wilson WR, Karchmer AW, Dajani AS, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. JAMA. 1995;274:1706-1713.
40. Baddour LM. Long-term suppressive antimicrobial therapy for intravascular device-related infections. Am J Med Sci. 2001;322:209-212.
41. Haas DW, Kaiser AB. Antimicrobial prophylaxis of infections associated with foreign bodies. In: Waldvogel FA, Bisno AL, eds. Infections Associated With Indwelling Medical Devices, 3rd ed. Washington, DC: ASM Press; 2000:395-406.
42. Da Costa A, Kirkorian G, Cucherat M, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation. 1998;97:1796-1801.
43. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med. 1998;339:1522-1533.
44. McCarthy PM, Schmitt SK, Vargo RL, et al. Implantable LVAD infections: implications for permanent use of the device. Ann Thorac Surg. 1996;61:359-365.
45. Holman WL, Park SJ, Long JW, et al; for the REMATCH Investigators: Infection in permanent circulatory support: experience from the REMATCH trial. J Heart Lung Transplant. 2004;23:1359-1365.
46. Gordon SM, Schmitt SK, Jacobs M, et al. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann Thorac Surg. 2001;72:725-730.
47. Simon D, Fischer S, Grossman A, et al. Left ventricular assist device-related infection: treatment and outcome. Clin Infect Dis. 2005;40:1108-1115.
48. Kasirajan V, McCarthy PM, Hoercher KJ, et al. Clinical experience with long-term use of implantable left ventricular assist devices: indications, implantation, and outcomes. Semin Thorac Cardiovasc Surg. 2000;12:229-237.
49. Goldberg SP, Baddley JW, Aaron MF, et al. Fungal infections in ventricular assist devices. ASAIO J. 2000;46:S37-S40.
50. Itescu S, Ankersmit JH, Kocher AA, et al. Immunobiology of left ventricular assist devices. Prog Cardiovasc Dis. 2000;43:67-80.
51. Sinha P, Chen JM, Flannery M, et al. Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation. 2000;102(suppl III):III194-III199.
52. Seeger JM. Management of patients with prosthetic vascular graft infection. Am Surg. 2000;66:166-177.
53. Pons VG, Wurtz R. Vascular graft infections: a 25-year experience of 170 cases. J Vasc Surg. 1991;13:751-752.
54. Bandyk DF, Novotney ML, Back MR, et al. Expanded application of in situ replacement for prosthetic graft infection. J Vasc Surg. 2001;34:411-420.
55. Delgado M, Prats E, Benito JL, et al. Scintigraphy with 99mTc-HMPAO labeled leukocytes and computed tomography in the diagnosis of vascular graft infection. A comparative study. Rev Esp Med Nucl. 1999;18:77-83.